21 CFR 106.6: Production and in-process control system
Requires infant formula manufacturers to implement a written production and in-process control system covering all stages, with specifications, monitoring, corrective actions, qualified documented review and disposition of failures, quarantine of nonconforming articles, and records.
Part 106, Infant Formula Requirements Pertaining to Current Good Manufacturing Practice, Quality Control Procedures, Quality Factors, Records and Reports, and Notifications · Subpart B, Current Good Manufacturing Practice
Recent 483s citing 106.6
- BlendHouse LLC · Reading, PennsylvaniaYou did not implement a system of production and iii-process controls for an infant… Jan 19, 2024
- Blend.Hous e LLC · Reading, PennsylvaniaYou did not establish a system of process controls covering all stages of… Dec 21, 2022
The regulation text
§ 106.6 Production and in-process control system.
(a)A manufacturer shall conform to the requirements of this subpart by implementing a system of production and in-process controls. This production and in-process control system shall cover all stages of processing, from the receipt and acceptance of the raw materials, ingredients, and components through the storage and distribution of the finished product and shall be designed to ensure that all the requirements of this subpart are met.
(b)The production and in-process control system shall be set out in a written plan or set of procedures that is designed to ensure that an infant formula is manufactured in a manner that will prevent adulteration of the infant formula.
(c)At any point, step, or stage in the production process where control is necessary to prevent adulteration, a manufacturer shall:
(1)Establish specifications to be met;
(2)Monitor the production and in-process control point, step, or stage;
(3)Establish a corrective action plan for use when a specification established in accordance with paragraph (c)(1) of this section is not met;
(4)Review the results of the monitoring required by paragraph (c)(2) of this section, and review and evaluate the public health significance of any deviation from specifications that have been established in accordance with paragraph (c)(1) of this section. For any specification established in accordance with paragraph (c)(1) of this section that a manufacturer fails to meet, an individual qualified by education, training, or experience shall conduct a documented review and shall make a material disposition decision to reject the affected article, to reprocess or otherwise recondition the affected article, or to approve and release the article for use or distribution; and
(5)Establish recordkeeping procedures, in accordance with § 106.100(e)(3), that ensure that compliance with the requirements of this section is documented.
(d)Any article that fails to meet a specification established in accordance with paragraph (c)(1) of this section shall be controlled under a quarantine system designed to prevent its use pending the completion of a documented review and material disposition decision.
Questions
What does 21 CFR 106.6 require?
Requires infant formula manufacturers to implement a written production and in-process control system covering all stages, with specifications, monitoring, corrective actions, qualified documented review and disposition of failures, quarantine of nonconforming articles, and records.
Which sections are cited alongside 106.6?
In the same 483s, investigators most often also cite 106.30 (Controls to prevent adulteration caused by equipment or utensils), 106.20 (Controls to prevent adulteration caused by facilities), 117.35 (Sanitary operations).